Cargando…

Outcome of Second Line Treatment of Recurrent High-Grade Glioma by re-Irradiation or Bevacizumab-based Chemotherapy: A Cross Sectional Study

INTRODUCTION: Currently, there is no standard of treatment for the management of the recurrent high-grade glioma. Re-resection, re-irradiation, and chemotherapy are among main treatment options without any proven efficacy. AIM: To compare the outcome of second line treatment of recurrent high-grade...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anvari, Kazem, Shahabadi, Mehri, Welsh, James S., Javadinia, Seyed Alireza, Zarei, Elham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495891/ https://www.ncbi.nlm.nih.gov/pubmed/37247269 http://dx.doi.org/10.31557/APJCP.2023.24.5.1507

Ejemplares similares

The role of large volume re-irradiation with Bevacizumab in chemorefractory high grade glioma
por: Chan, Joseph, et al.
Publicado: (2020)

Re-irradiation alternatives for recurrent high-grade glioma
por: Dong, Yuanli, et al.
Publicado: (2016)

Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients
por: Niyazi, Maximilian, et al.
Publicado: (2014)

Bevacizumab combined with re-irradiation in recurrent glioblastoma
por: She, Lei, et al.
Publicado: (2022)

A Review of the Role of Re-Irradiation in Recurrent High-Grade Glioma (HGG)
por: Amichetti, Maurizio, et al.
Publicado: (2011)

Re-irradiation for high-grade gliomas: Has anything changed?
por: García-Cabezas, Sonia, et al.
Publicado: (2021)

Primary duodenal malignant melanoma: A case report
por: Anvari, Kazem, et al.
Publicado: (2018)

Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023)

Temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade gliomas
por: La Rosa, Alonso, et al.
Publicado: (2023)

Long-Term Survival of Cutaneous Malignant Melanoma with Metastasis to Paranasal Sinuses: A Case Report and Literature Review
por: Anvari, Kazem, et al.
Publicado: (2018)

Expert consensus on re-irradiation for recurrent glioma
por: Krauze, Andra, et al.
Publicado: (2017)

Concurrent immunotherapy and re‐irradiation utilizing stereotactic body radiotherapy for recurrent high‐grade gliomas
por: Mahase, Sean S., et al.
Publicado: (2023)

Imaging-Based Patterns of Failure following Re-Irradiation for Recurrent/Progressive High-Grade Glioma †
por: Datta, Debanjali, et al.
Publicado: (2023)

Re-irradiation combined with bevacizumab for recurrent glioblastoma beyond bevacizumab failure: survival outcomes and prognostic factors
por: You, Weir-Chiang, et al.
Publicado: (2023)

RE-IRRADIATION FOR RECURRENT HIGH-GRADE GLIOMA: AN ANALYSIS OF PROGNOSTIC FACTORS FOR SURVIVAL AND PREDICTORS OF RADIATION NECROSIS
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

The prevalence and expression pattern of melanoma-associated antigen 1 in esophageal squamous cell carcinoma: a historical cohort study
por: Anvari, Kazem, et al.
Publicado: (2017)

Correction to expert consensus on re-irradiation for recurrent glioma
por: Krauze, Andra V., et al.
Publicado: (2018)

Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors
por: Lee, Jeongshim, et al.
Publicado: (2016)

LMAP-10 RE-IRRADIATION FOR RECURRENT ADULT DIFFUSE GLIOMA
por: Zhou, Jiangfen, et al.
Publicado: (2023)

COVID-19 Vaccination and Cancer, the Need for more Data
por: Javadinia, Seyed Alireza, et al.
Publicado: (2021)

Re-irradiation for recurrent or second primary head and neck cancer
por: Lee, Hye In, et al.
Publicado: (2021)

Second course of re-irradiation in pediatric diffuse intrinsic pontine glioma: A case study
por: Bergengruen, Paula Maria, et al.
Publicado: (2023)

Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes
por: Bovi, Joseph A., et al.
Publicado: (2020)

COT-21 EFFECT OF BEVACIZUMAB FOR PEDIATRIC HIGH GRADE GLIOMA
por: Tsukamoto, Yoshihiro, et al.
Publicado: (2019)

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma
por: Vordermark, Dirk, et al.
Publicado: (2005)

Re-irradiation with stereotactic radiotherapy for recurrent high-grade glial tumors
por: Soykut, Ela Delikgoz, et al.
Publicado: (2023)

Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence
por: Christ, Sebastian M., et al.
Publicado: (2023)

Chemotherapy for high-grade gliomas
por: Galanis, E, et al.
Publicado: (2000)

Opium poisoning following self‐medication of radiation‐induced dermatitis with topical use of opium latex traditional extract; a teaching case
por: Dehghani, Mansoureh, et al.
Publicado: (2021)

Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
por: Detti, Beatrice, et al.
Publicado: (2021)

Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low‐grade glioma
por: Zhukova, Nataliya, et al.
Publicado: (2018)

Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma
por: Kessel, Kerstin A., et al.
Publicado: (2017)

Re-surgery and chest wall re-irradiation for recurrent breast cancer - a second curative approach
por: Müller, Arndt-Christian, et al.
Publicado: (2011)

Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial
por: Cohen, Adam L., et al.
Publicado: (2020)

Second Re-irradiation: Clinical Examples of Worthwhile Treatment
por: Nieder, Carsten, et al.
Publicado: (2018)

Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review
por: Kulinich, Daniel P., et al.
Publicado: (2021)

Second Surgery in Insular Low-Grade Gliomas
por: Ius, Tamara, et al.
Publicado: (2015)

Relief Effect of Bevacizumab on Severe Edema Induced by Re-irradiation in Brain Tumor Patients
por: Shen, Ge, et al.
Publicado: (2015)

Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation
por: Fleischmann, Daniel F., et al.
Publicado: (2019)

An Overview of Fotemustine in High-Grade Gliomas: From Single Agent to Association with Bevacizumab
por: Lombardi, Giuseppe, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7615iiqgajjn2m9gv7cisi6ne7